 |
Catalogue |
 |
 |
Main Products |
 |
|
|
 |
Products |
 |
No. |
Product Name |
CAS No. |
Spec |
Price |
|
1040683 |
Apigenin (30 mg) |
520-36-5 |
|
|
1040708 |
Apigenin-7-glucoside (30 mg) |
N/A |
|
|
1040854 |
Apocarotenal (3 x 50 mg) (Beta-Apo-8’-Carotenal) |
1107-26-2 |
|
|
1041609 |
Apraclonidine Hydrochloride (100 mg) |
73218-79-8 |
|
|
1041904 |
Aprepitant (50 mg) |
170729-80-3 |
|
|
1041915 |
Aprepitant Related Compound A (10 mg) (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) |
1148113-53-4 |
|
|
1041926 |
Aprepitant Related Compound B (10 mg) (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) |
172822-29-6 |
|
|
1042102 |
L-Arabinitol (500 mg) |
7643-75-6 |
|
|
1042500 |
L-Arginine (200 mg) |
74-79-3 |
|
|
1042554 |
Arginine Ethyl Ester Dihydrochloride (250 mg) |
36589-29-4 |
|
|
1042601 |
Arginine Hydrochloride (125 mg) |
1119-34-2 |
|
|
1042634 |
Aripiprazole (200 mg) |
129722-12-9 |
|
|
1042645 |
Aripiprazole Related Compound B (25 mg) (7-(4-hydroxy-butoxy)-3,4-dihydroquinolin-2(1H)-one) |
889443-20-3 |
|
|
1042656 |
Aripiprazole Related Compound C (25 mg) (1-(2,3-dichlorophenyl)piperazine hydrochloride) |
119532-26-2 |
|
|
1042689 |
Aripiprazole Related Compound F (25 mg) (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide) |
573691-09-5 |
|
|
1042690 |
Aripiprazole Related Compound G (25 mg) (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one) |
129722-25-4 |
|
|
1042703 |
Arsanilic Acid (25 mg) |
98-50-0 |
|
|
1042714 |
Aripiprazole Related Compound H (25 mg) (7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one) |
N/A |
|
|
1042780 |
Artemether (100 mg) |
71963-77-4 |
|
|
1042791 |
Artemether Related Compound A (15 mg) ((3R,5aS,6R,8aS,9R,12R,12aR)-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin) |
71939-50-9 |
|
|
|
|
|